Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes

Journal of Cellular Biochemistry

Volumn 91, Issue 4, 2004, Pages 777-785

  Park, Chan Hee ^a   Kim, Hak Ryul ^b   Kim, Ju ^a   Jang, Sun Hee ^a   Lee, Kyung Yeol ^a   Chung, Gook Hyun ^a   Jang, Yong Suk ^a  

^a Chonbuk National University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Cell cycle; Epstein Barr virus; Latent membrane protein; Serum starvation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; LATENT MEMBRANE PROTEIN 1; PROTEIN P27; REGULATOR PROTEIN; TRANSCRIPTION FACTOR E2F4; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; DNA BINDING PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL CYCLE; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; WESTERN BLOTTING; CELL LINE; CULTURE MEDIUM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; VIRAL MATRIX PROTEINS;

EID: 16544378345     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10776     Document Type: Article

References (39)

1. Baichwal VR, Sugden B. 1988. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2:461-467.
2. Balasubramanian S, Ahmad N, Jeedigunta S, Mukhtar H. 1998. Alterations in cell cycle regulation in mouse skin tumors. Biochem Biophys Res Commun 243:744-748.
3. 1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16:3461-3469.
4. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. 1999. The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583.
5. Cuomo L, Ramquist T, Trivedi P, Wang F, Klein G, Masucci MG. 1992. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability, and tumorigenicity of an EBV-negative Burkitt lymphoma line. Int J Cancer 51:949-955.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
7. Ewen ME, Xing YG, Lawrence JB, Livingston DM. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
8. Farrell PJ. 1995. Epstein-Barr virus immortalizing genes. Trends Microbiol 3:105-109.
9. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CB, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X. 1997. High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94:6380-6385.
10. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K. 1996. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol 134:13-23.
11. Hasan NM, Adams GE, Joiner MC. 1999. Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: Implications for cell death. Int J Cancer 80:400-405.
12. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
13. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G. 1993. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575-1583.
14. Hunter T, Pines J. 1991. Cyclins and cancer. Cell 66:1071-1074.
15. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
16. Kawa K. 2000. Epstein-Barr virus-associated diseases in humans. Int J Hematol 71:108-117.
17. Kaye KM, Izumi KM, Kieff E. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90: 9150-9154.
18. 1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14: 88-96.
19. Kim H-R, Jeong JA, Park C-H, Lee S-K, Lee W-K, Jang Y-S. 2002. A role for cell cycle proteins in the serum-starvation resistance of Epstein-Barr virus immortalized B lymphocytes. Biochem Cell Biol 80:407-413.
20. Kip1. J Pathol 190:604-612.
21. Kondo T, Higashi H, Nishizawa H, Ishikawa S, Ashizawa S, Yamada M, Makita Z, Koike T, Hatakeyama M. 2001. Involvement of pRB-related p107 protein in the inhibition of S phase progression in response to genotoxic stress. J Biol Chem 276:17559-17567.
22. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862.
23. Lee WK, Kim SM, Sim YS, Cho SG, Park SH, Kim CW, Park JG. 1998. B-lymphoblastoid cell lines from cancer patients. In Vitro Cell Dev Biol Anim 34:97-100.
24. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. 1993. The adenovirus E1A-associated 130-kDa protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7: 2366-2377.
25. Nicholson LJ, Hopwood P, Johannessen I, Salisbury JR, Codd J, Thorley-Lawson D, Crawford DH. 1997. Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells. Oncogene 15:275-283.
26. O'Connor RJ, Schaley JE, Feeney G, Hearing P. 2001. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. Oncogene 20: 1882-1891.
27. Okano M, Gross TG. 2000. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci 319:392-396.
28. Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G. 1993. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 8:1049-1054.
29. Rowe M, Peng-Pilon M, Huen DS, Hardy R, Croom-Carter D, Lundgren E, Rickinson AB. 1994. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. J Virol 68:5602-5612.
30. Sinclair AJ, Palmero I, Holder A, Peters G, Farrell PJ. 1995. Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene. J Virol 69:1292-1295.
31. 1 progression. Oncogene 9:2663-2674.
32. Tomkinson B, Robertson E, Kieff E. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67:2014-2025.
33. 1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
34. Vockerodt M, Haier B, Buttgereit P, Tesch H, Kube D. 2001. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway. Virology 280:183-198.
35. Waga S, Hannon GJ, Beach D, Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
36. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
37. Wang S, Rowe M, Lundgren E. 1996. Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res 56: 4610-4613.
38. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
39. 2 phases by trichostatin A. Exp Cell Res 177:122-131.